IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden
· Delayed Price · Currency is SEK 7.29
-0.11 (-1.49%)
May 9, 2025, 5:29 PM CET
IRLAB Therapeutics AB Revenue
IRLAB Therapeutics AB had revenue of 8.06M SEK in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 102.69M, up 1,708.47% year-over-year. In the year 2024, IRLAB Therapeutics AB had annual revenue of 94.63M with 1,566.57% growth.
Revenue (ttm)
102.69M
Revenue Growth
+1,708.47%
P/S Ratio
3.63
Revenue / Employee
3.31M
Employees
31
Market Cap
372.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94.63M | 88.95M | 1,566.57% |
| Dec 31, 2023 | 5.68M | -55.46M | -90.71% |
| Dec 31, 2022 | 61.14M | -146.65M | -70.58% |
| Dec 31, 2021 | 207.78M | 207.48M | 69,160.67% |
| Dec 31, 2020 | 300.00K | -72.00K | -19.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |